Published • loading... • Updated
Makary Resigns as FDA Commissioner
The departure follows weeks of pressure over drug reviews, flavored vaping products and mifepristone, while six people led the FDA drug center in a year.
- On Tuesday, FDA Commissioner Marty Makary stepped down after 13 months leading the agency, with Kyle Diamantas expected to serve as acting commissioner following a decision by Health and Human Services Secretary Robert F. Kennedy Jr. and White House approval.
- Makary's tenure faced months of internal turmoil marked by sweeping layoffs, turnover among senior leadership, and repeated clashes with lawmakers and the pharmaceutical industry over his handling of mifepristone and flavored vapes.
- Last Tuesday, the FDA authorized fruit-flavored vapes fulfilling a 2024 campaign promise, while the Supreme Court recently allowed nationwide mifepristone access despite Republicans continuing to push for reversals of telehealth dispensing rules.
- This departure marks the administration's fourth high-profile exit this year, following Labor Secretary Lori Chavez DeRemer's April resignation and the removal since January of Homeland Security Secretary Kristi Noem and Attorney General Pam Bondi.
- Regulatory uncertainty now surrounds the FDA's enforcement priorities, as the agency has not released its review of abortion pills—a process Makary reportedly asked officials to delay until after the midterms.
Insights by Ground AI
Podcasts & Opinions
133 Articles
133 Articles
Makary Resigns as FDA Commissioner
(MedPage Today) -- FDA Commissioner Marty Makary, MD, MPH, resigned on Tuesday after just over a year at the agency and days of speculation about whether he'd be fired. Kyle Diamantas, the agency's deputy commissioner for food, was named as the...
·New York, United States
Read Full Article
Trump FDA chief resigning; angered pharma CEOs, vaping lobbyists, anti-abortion groups
WASHINGTON — The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of complaints from health industry executives, anti-abortion activists, vaping lobbyists and other allies of President Donald Trump.News of Makary’s departure Tuesday came just 13 months after he was confirmed to lead the powerful regulatory agency.A surgeon and health researcher, Makary came to prominence among Republi…
·Chicago, United States
Read Full Article
Coverage Details
Total News Sources133
Leaning Left25Leaning Right16Center67Last UpdatedBias Distribution62% Center
Bias Distribution
- 62% of the sources are Center
62% Center
L 23%
C 62%
15%
Factuality
To view factuality data please Upgrade to Premium
